Last update Feb. 5, 2022
Limited compatibility
We do not have alternatives for D08AH30; D09AA10; G01AC02; P01AA02; S02AA05.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
D08AH30; D09AA10; G01AC02; P01AA02; S02AA05 is Clioquinol in ATC Code/s.
Is written in other languages:D08AH30; D09AA10; G01AC02; P01AA02; S02AA05 is also known as
D08AH30; D09AA10; G01AC02; P01AA02; S02AA05 belongs to these groups or families:
Main tradenames from several countries containing D08AH30; D09AA10; G01AC02; P01AA02; S02AA05 in its composition:
Variable | Value | Unit |
---|---|---|
Oral Bioavail. | (derm: 3 a 40 ) | % |
Molecular weight | 306 | daltons |
pKa | 7.34 | - |
T½ | 11 - 14 | hours |
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Clioquinol is a halogenated hydroxyquinoline with antibacterial and antifungal properties. It is used topically in the form of creams in the treatment of skin infections and in liquid form for infections of the external ear.
At the date of the last update, there was no published data available on its excretion in human milk.
It is absorbed through the skin in an amount that could be significant, especially as an occlusive cure. (AEMPS 2008, Wilcock 1985, Stohs 1984, Fischer 1978)
Systemic clioquinol is highly neurotoxic, can cause blindness and neuropathy; it should not be used in infants. (AAP 1990)
If used, do not apply on the breast area, or in places on the maternal skin that the infant can reach, or in large areas, or as an occlusive cure or for prolonged periods to avoid increasing systemic absorption.